DEPUY ORTHOPAEDICS, INC. INTRODUCES LCS® COMPLETE™ RPS FLEXION KNEE
Latest Design Brings Increased Flexion to the World’s First and Leading Mobile Bearing Total Knee System
WARSAW, IN (September 12, 2008) – DePuy Orthopaedics, Inc., announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for the LCS® Complete™ RPS Flexion Knee. The LCS Complete RPS Flexion Knee offers today’s high demand patients the potential for increased flexion based upon a proven knee system with 30 years of clinical success.
“The new LCS Complete RPS Flexion is engineered to offer patients optimum function with maximum durability,” explains Dr. Lawrence Crossett, Orthopaedic Surgeon at the University of Pittsburgh Medical Center and one of the designers of this device. “This offering is especially important as patients have become more demanding of what lifestyle and activities they wish to pursue following surgery.”
The performance of knee replacements depends on age, weight, activity level, and other factors. There are potential risks and recovery takes time. People with conditions limiting rehabilitation should not have this surgery. Only an orthopaedic surgeon can tell if knee replacement is right for a patient.
About DePuy Orthopaedics, Inc.
DePuy Orthopaedics, Inc., a Johnson & Johnson company, is advancing the standard of orthopaedic patient care, with a focused commitment to help surgeons achieve excellence
in surgical practice. The company designs, manufactures and distributes orthopaedic devices and supplies including hip, knee, extremity, trauma, cement, orthobiologics, and operating room products. As a global leader in joint replacement products, DePuy Orthopaedics is committed to Restoring the Joy of Motion® for patients whose mobility is restricted by severe osteoarthritis or other debilitating injury.